WILLIAMS AND JENSEN, PLLC for GENENTECH INC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
R&D Tax Credit Extension; TARP; and tax extenders
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID E FRANASIAK | — |
| JACK STEVEN HART | — |
| CHRISTOPHER W HATCHER | — |
Copyright/Patent/Trademark CPT
Intellectual property issues and Pathways to Biosimilars Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK STEVEN HART | — |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Health Issues HCR
Medicare Improvements for Patients and Providers Act; Pathway for Biosimilars Act; FDA Reform; and Medicare Drug Benefit
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK STEVEN HART | — |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Budget/Appropriations BUD
Consoldidated Security, Disaster Assistance and Continuing Appropriations Act; Comparative Effectiveness legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK STEVEN HART | — |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Medicare/Medicaid MMM
Emergency Economic Stabilization Act; Physician Payments Sunshine Act; Medicare Improvenents for Patients and Providers Act; and Comparative Effectiveness Legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK STEVEN HART | — |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.